Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial

BACKGROUND: A large liver size is a factor that may increase the difficulty of bariatric surgery (BS) and unwanted complications. Some agents have been used to decrease the liver size before BS. Silymarin has been used as an antioxidant agent to improve liver function tests. This study was designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Atarodi, Hamed, Pazouki, Abdolreza, Gholizadeh, Barmak, Karami, Reza, Kabir, Ali, Sadri, Ghazal, Kassir, Radwan, Kermansaravi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693701/
https://www.ncbi.nlm.nih.gov/pubmed/36438071
http://dx.doi.org/10.4103/jrms.jrms_683_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693701/
https://www.ncbi.nlm.nih.gov/pubmed/36438071
http://dx.doi.org/10.4103/jrms.jrms_683_21

Ejemplares similares